Are Endothelial Cell and Granulocyte Protein Arginine Deiminase 4 on the Pathway of Inflammasome-Activation, Advancing Myocardial Ischemia Reperfusion Injury?
内皮细胞和粒细胞蛋白精氨酸脱亚胺酶 4 是否在炎症小体激活途径中,促进心肌缺血再灌注损伤?
基本信息
- 批准号:440378203
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Research Fellowships
- 财政年份:2020
- 资助国家:德国
- 起止时间:2019-12-31 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
With the advances in percutaneous coronary intervention technology, the prognosis of patients with acute coronary syndrome has improved significantly over the last decades. However, approximately 6% of admitted patients do not survive hospital discharge and a decrease in cardiac function is still a common consequence of acute myocardial infarction, despite vigorous medical therapy. Increasing clinical and experimental evidence suggests that revascularisation itself triggers a pathological response termed myocardial ischemia-reperfusion (M/IR) injury. Experimental and clinical data suggests that MI/R injury may be responsible for up to 50% of the ultimate infarction area.Since the first description of M/IR injury by Jennings et al. in the 1960s it became evident that M/IR injury is an inflammatory-driven mechanism, in part depending on the infiltration of bone-marrow derived cells as well as the activation of classic inflammatory pathways. To unravel the pathophysiology of this process could help to attenuate M/IR injury. In 2014 Gao C. et al. discovered the activation of NLRP3-Inflammasome, a cytosolic protein complex that mediates the activation of pro-inflammatory caspases, ultimately resulting in the secretion of cytokines of the interleukin-1 family, in cardiac microvascular endothelial cells (CMECs) as a novel mechanism of MI/R injury. As of August 2019 Mishra N et al. showed that the Protein Arginine Deiminase 4 regulates NLRP3 Inflammasome activation in macrophages.In 2019 Wagner et al. demonstrated that NLRP3 Inflammasome activation plays an important role in the process of granulocyte Neutrophil Extracellular Traps (NETs) release, a form of defence mechanism originally intended to immobilize invading microorganisms consisting of a DNA scaffold decorated with granule-derived proteins. Over the years NETs have been implicated in a growing list of autoimmune and inflammatory conditions and in 2015 Ge L. et al. provided evidence for the existence of NETs in MI/R injury challenged myocardium. Whether endothelial cell and granulocyte Protein Arginine Deiminase 4 are on the pathway of Inflammasome activation and thus advancing myocardial ischemia reperfusion injury is yet to be established.The aim of the proposed project is to further investigate pro-inflammatory signalling pathways of MI/R injury in a mouse model using short-term ligation of the left anterior descending artery. Ex-vivo methods such as histology, gen expression analysis of blood and endothelial cells, protein analysis, flow cytometry and Immunofluorescence microscopy will be used. A comparative analysis of PAD4-/--, WT- and NLRP3-/-- mice will help to single out their individual function in MI/R injury potentially unveiling novel therapeutic modalities in attenuating MI/R injury.
随着经皮冠状动脉介入治疗技术的进步,急性冠状动脉综合征患者的预后在过去几十年中得到了显着改善。然而,大约 6% 的入院患者无法出院,尽管采取了积极的药物治疗,但心功能下降仍然是急性心肌梗死的常见后果。越来越多的临床和实验证据表明,血运重建本身会引发一种称为心肌缺血再灌注(M/IR)损伤的病理反应。实验和临床数据表明,MI/R 损伤可能导致高达 50% 的最终梗塞面积。自从 Jennings 等人首次描述 M/IR 损伤以来。在 20 世纪 60 年代,人们发现 M/IR 损伤是一种炎症驱动的机制,部分取决于骨髓来源细胞的浸润以及经典炎症途径的激活。阐明这一过程的病理生理学可能有助于减轻 M/IR 损伤。 2014年,Gao C.等人。发现 NLRP3-炎症小体(一种胞浆蛋白复合物,介导促炎性半胱天冬酶的激活,最终导致心脏微血管内皮细胞 (CMEC) 中白细胞介素-1 家族细胞因子的分泌)的激活是 MI/R 损伤的一种新机制。截至 2019 年 8 月,Mishra N 等人。表明蛋白质精氨酸脱亚胺酶 4 调节巨噬细胞中 NLRP3 炎症小体的激活。2019 年,Wagner 等人。证明 NLRP3 炎症小体激活在粒细胞中性粒细胞胞外陷阱 (NET) 释放过程中发挥重要作用,NET 是一种防御机制,最初旨在固定入侵的微生物,由装饰有颗粒衍生蛋白的 DNA 支架组成。多年来,NETs 与越来越多的自身免疫和炎症性疾病有关,2015 年 Ge L. 等人。为 MI/R 损伤心肌中存在 NET 提供了证据。内皮细胞和粒细胞蛋白精氨酸脱亚胺酶 4 是否在炎症小体激活途径上,从而促进心肌缺血再灌注损伤尚待确定。该项目的目的是通过短期结扎左前降支动脉,进一步研究小鼠模型中 MI/R 损伤的促炎信号传导途径。将使用诸如组织学、血液和内皮细胞的基因表达分析、蛋白质分析、流式细胞术和免疫荧光显微镜等离体方法。对 PAD4-/--、WT- 和 NLRP3-/-- 小鼠的比较分析将有助于找出它们在 MI/R 损伤中的个体功能,有可能揭示减轻 MI/R 损伤的新治疗方式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dr. Lukas Heger其他文献
Dr. Lukas Heger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
- 批准号:QN25H220002
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
- 批准号:
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
- 批准号:TGY24H080011
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
- 批准号:82305053
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向Cell-Free网络的协同虚拟化与动态传输
- 批准号:62371367
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
- 批准号:82373069
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
- 批准号:82273886
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
- 批准号:
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
- 批准号:2021JJ30609
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Identification of novel granulocyte/monocyte progenitors and elucidation of myeloid cell developmental pathway
新型粒细胞/单核细胞祖细胞的鉴定和骨髓细胞发育途径的阐明
- 批准号:
22H02855 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of scientific basis for iPS cell-rerived granulocyte transfusion strategy
iPS细胞衍生粒细胞输注策略的科学依据的建立
- 批准号:
26860474 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Young Scientists (B)
Stem cell therapy for psychiatric disorders using granulocyte-colony stimulating factor
使用粒细胞集落刺激因子干细胞治疗精神疾病
- 批准号:
23591678 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
The coadministration of granulocyte colony-stimulating factor and stem cell factor to secondary injury after spinal cord injury(Analysis of endplasmic reticulum stress response)
粒细胞集落刺激因子与干细胞因子联合应用对脊髓损伤后继发性损伤的影响(内质网应激反应分析)
- 批准号:
21591907 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Involvement of ets oncogene family in chromosomal translocation and hemopoietic cell dofferentiation into granulocyte/macrophage lineage
ET癌基因家族参与染色体易位和造血细胞分化为粒细胞/巨噬细胞谱系
- 批准号:
03807164 - 财政年份:1991
- 资助金额:
-- - 项目类别:
Grant-in-Aid for General Scientific Research (C)














{{item.name}}会员




